Right Turn: Research at the bleeding edge. Literally.

How many university students can say they invented a product that people around the world will want to use? For that matter, how many people have ever invented a product that made it to the market?!

Joe Landolina is CEO and Co-Founder of Suneris, Inc. and a student at the Polytechnic Institute of New York University. Joe has created a biomaterial that quickly stops bleeding in wounds and his gel, Veti-Gel, even works on severe burns, internal organs and major arteries to close them. The Suneris website explains that the technology is plant-derived and mimics the skin’s composition. It works by “promoting fibrin production, replicating the body’s natural [extracellular matrix] and promoting platelet activation.” Similar research is being conducted in Canada.

Apparently the United States military is a potential client. Not bad for a 20-year-old. Or anyone.

Warning: the video below shows a fresh pork loin being sliced open to demonstrate how Veti-Gel stops the flow of blood.

http://www.youtube.com/watch?v=uS9BfgBpCSI

Our regular feature, Right Turn, showcases the “lighter” side of stem cells and regenerative medicine. Every Friday, we will bring you cartoons, photos, videos and other content that may be just as thought provoking as the written submissions that you are used to finding here, but they definitely won’t be blogs.

As always, we welcome your feedback and we also welcome suitable submissions. Be creative! Use the right (!) side of your brain. Make us laugh! Let’s see if we can make this new direction a positive one for all of us. Send your submission to info(at)ccrm.ca.

The following two tabs change content below.

• Bio
• Latest Posts

Stacey Johnson

Stacey Johnson is the editor of Signals and a contributor. For 25 years, Stacey has been providing strategic communications counsel to government, corporate, technology and health organizations. She began her career at the CTV Television Network and then moved to Hill & Knowlton Canada where she advised clients in a variety of industries and sectors. Stacey is the Vice President, Communications and Marketing for CCRM, a leader in developing and commercializing regenerative medicine-based technologies and cell and gene therapies. She has a Master's degree in Public Relations. You can follow her on Twitter @msstaceyerin.

Latest posts by Stacey Johnson (see all)

• Right Turn: #pinksocks, diabetes news and other ramblings - June 24, 2025
• Right Turn: Some takeaways from Advanced Therapies Week 2025 - January 31, 2025
• Right Turn: The top 10 most-read blog posts in 2024 - January 2, 2025